OncoMax Presented its Project at the Skolkovo Foundation Board Meeting

The meeting of the Skolkovo Fund Board with the participation of the President of the Russian Federation Dmitry Medvedev took place in Bauman Moscow State Technical University on April 25. As part of the events confined to the meeting there was an exhibition of flagship projects of Skolkovo Foundation, including OncoMax that presented its project on the development and introduction to the market of the innovative drug OM-RCA-01 for treatment of kidney cancer.

At the exhibition the Chief Scientific Adviser of the company, Dr. Ilya Tsimafeyeu, submitted the latest achievements and perspectives in project development to the following Board members: Elvira Nabiullina, Minister of Economic Development of the Russian Federation, Igor Agamirzyan, CEO and Chairman of the Board of Directors of RVC OJSC,  and Anatoly Chubais, Chairman of the Board of Directors of ROSNANO OJSC . All of them carefully studied the submitted results of OncoMax activity and demonstrated interest in the development of the project based on the discovery of Russian scientists which has been already recognized by the global scientific community. 


Анна Зеленкова,
PR директор, ООО «Максвелл Биотех Групп»;
Тел: +7 (495) 411-6992
E-mail: zelenkova@maxwellbiotech.ru

 Исследования осуществляются ООО «ОнкоМакс» при грантовой поддержке Фонда «Сколково».